ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

CDNA CareDx Inc

9.18
1.42 (18.30%)
May 01 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 2,600,124
Bid Price 9.15
Ask Price 9.32
News -
Day High 9.96

Low
4.80

52 Week Range

High
12.93

Day Low 8.43
Share Name Share Symbol Market Stock Type
CareDx Inc CDNA NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
1.42 18.30% 9.18 18:18:29
Open Price Low Price High Price Close Price Previous Close
8.51 8.43 9.96 9.18 7.76
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
25,062 2,600,124 US$ 9.08 US$ 23,620,966 - 4.80 - 12.93
Last Trade Type Quantity Price Currency
17:13:00 1 US$ 9.18 USD

CareDx Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
475.84M 51.78M - 280.32M -190.28M -3.68 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

CareDx News

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No CDNA Message Board. Create One! See More Posts on CDNA Message Board See More Message Board Posts

Historical CDNA Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week8.209.967.427.84672,2690.9811.95%
1 Month9.8410.307.428.50627,550-0.66-6.71%
3 Months8.9912.83377.429.68785,8290.192.11%
6 Months5.5312.935.209.551,036,9443.6566.00%
1 Year8.1012.934.809.01936,9071.0813.33%
3 Years79.7896.884.8023.42893,684-70.60-88.49%
5 Years27.4199.834.8028.94821,093-18.23-66.51%

CareDx Description

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a leading provider of genomics-based information for transplant patients. Its primary operations are in Brisbane, California; Omaha, Nebraska; Fremantle, Australia and Stockholm, Sweden.

Your Recent History

Delayed Upgrade Clock